If you and your partner have been trying to conceive without success, evaluating male fertility is not an optional sidebar; it represents exactly half of the clinical picture. Worldwide, male factor infertility contributes to nearly 50% of all couple infertility cases. Yet, due to deep cultural stigmas and clinical misconceptions, men are frequently evaluated late or incompletely, delaying vital diagnostic breakthroughs.
Modern guidelines emphasize that concurrent screening of both partners from the very first consultation is the fastest path to success. Because male infertility can stem from entirely distinct cellular and anatomical roots ranging from silent hormonal deficits and physical varicoceles to hidden sperm DNA strand breaks there is no single cure-all.
This comprehensive guide breaks down the standard WHO semen analysis parameters, explores the main categories of male fertility disorders, and highlights the precise medical, lifestyle, and assisted reproductive treatments available to help you build an effective, targeted solution.
Why Male Infertility Remains Underreported and Undertreated
Male factor infertility contributes to approximately half of all couple infertility cases worldwide. Yet in clinical practice, the male partner is frequently evaluated late, incompletely, or not at all. Cultural stigma around male fertility remains significant in India, and many men associate a fertility evaluation with a judgment on their masculinity. Neither the stigma nor the association is medically relevant. Both prevent timely diagnosis and treatment.
As the American Urological Association's 2024 updated guideline on male infertility confirms, clinicians should initiate concurrent assessment of both male and female partners at the outset of any infertility evaluation. Couple infertility may be due to male factors, female factors, or a combination. Both partners are equal stakeholders in both diagnosis and treatment.
The most important thing to understand about male infertility treatment is that there is no single correct approach. The right treatment for one man may be completely wrong for another, because male infertility is caused by conditions as different as hormonal imbalance, physical obstruction, genetic factors, and lifestyle damage. Treatment that does not match the underlying cause does not work. This is why the evaluation always comes before the treatment decision.
How Male Infertility Is Assessed
The foundation of any male fertility evaluation is the semen analysis. This test measures sperm concentration, total motility, progressive motility, and morphology against the WHO 2021 reference parameters. These thresholds represent the minimum values below which a significant proportion of men will experience fertility difficulty:
- Sperm concentration: 16 million per mL or above
- Total motility: 42% or above
- Progressive motility: 30% or above
- Normal morphology (Kruger strict criteria): 4% or above
A single abnormal semen analysis is not definitive. As the AUA/ASRM 2024 guideline notes, two or more semen analyses separated by at least 4 weeks are needed to reliably characterise sperm parameters, because significant natural variation occurs between samples. Results must always be interpreted alongside the clinical history, physical examination, and hormonal testing.
Beyond the semen analysis, a complete male fertility evaluation includes hormonal profile (FSH, LH, testosterone, prolactin), physical examination by an andrologist including assessment for varicocele, scrotal ultrasound, karyotyping when indicated, Y-chromosome microdeletion testing for men with severe oligozoospermia or azoospermia, and sperm DNA fragmentation testing, which provides information about sperm genetic quality that the standard analysis does not capture.
Category 1: Pre-Testicular Causes and Hormonal Treatment
Pre-testicular infertility refers to conditions outside the testes that affect hormone signalling, and therefore impair the hormonal drive needed for sperm production.
The most significant pre-testicular cause is hypogonadotropic hypogonadism (HH): a condition where the pituitary gland produces insufficient FSH and LH, the hormones that stimulate the testes to produce both testosterone and sperm. Without adequate FSH, spermatogenesis cannot proceed. The testes themselves may be structurally healthy, but they lack the hormonal signal to function.
Causes of HH include pituitary tumours (prolactinomas), Kallmann syndrome (a genetic condition where the hypothalamus does not produce GnRH), prolonged use of anabolic steroids or testosterone supplements, and other pituitary disorders.
The AUA/ASRM 2024 guideline specifically states that in patients presenting with hypogonadotropic hypogonadism, clinicians should evaluate the patient to determine the etiology and treat based on diagnosis. Treatment options include gonadotropin therapy (injections of FSH and hCG to directly stimulate sperm production), pulsatile GnRH therapy, and for borderline cases, selective estrogen receptor modulators (SERMs) or aromatase inhibitors to optimise the hormonal environment. When the hormonal cause is identified and treated appropriately, sperm production can be restored in the majority of cases.
This is why hormonal evaluation is mandatory in every male fertility workup: a man with hypogonadotropic hypogonadism treated with testosterone rather than with gonadotropins will experience worsened, not improved, fertility, because testosterone supplementation suppresses the pituitary signals that drive sperm production.
Category 2: Testicular Causes and Varicocele Treatment
Testicular infertility refers to conditions within the testes that impair sperm production despite normal hormonal signalling. This is the largest and most clinically diverse category of male infertility.
Varicocele is the most common surgically correctable cause of male infertility. It is an abnormal dilation of the veins within the scrotum (the pampiniform plexus) that raises intrascrotal temperature, impairs testicular blood drainage, and over time damages sperm production. Varicocele is present in 19 to 41% of men with primary infertility and 45 to 81% of men with secondary infertility, indicating it is a progressive condition that worsens over time without treatment.
A 2024 Indian study published in NCBI, conducted across infertile men evaluated in India, found that varicocele was independently associated with azoospermia (adjusted OR 3.23) and oligozoospermia (OR 2.71), confirming its clinical significance in the Indian male infertility population. Microsurgical varicocelectomy is the gold-standard surgical treatment, and a 2025 meta-analysis confirmed that microsurgical varicocelectomy significantly improved sperm concentration, motility, and sperm DNA fragmentation compared to antioxidant therapy alone.
Genetic causes include Klinefelter syndrome (47,XXY karyotype), the most common chromosomal cause of primary testicular failure; Y-chromosome microdeletions in the AZF regions (found in 3.2% of Indian infertile men in a 2026 JARG study); and single-gene mutations affecting spermatogenesis. Genetic causes typically result in severe oligozoospermia or azoospermia and are diagnosed through karyotyping and Y-chromosome microdeletion testing. Treatment depends on the specific finding: some men with AZFc deletions can still have sperm retrieved surgically; AZFa and AZFb deletions typically indicate complete absence of sperm in the testes.
Idiopathic testicular failure refers to impaired sperm production with no identifiable cause after full evaluation. It accounts for a significant proportion of male infertility cases. Management options include antioxidant therapy (Vitamin C, Vitamin E, CoQ10, zinc, folate) to reduce oxidative stress on developing sperm, empirical hormonal stimulation, and ART depending on the degree of impairment.
Category 3: Post-Testicular Causes and Surgical Correction
Post-testicular infertility occurs when sperm are produced normally by the testes but cannot be delivered through the reproductive tract due to obstruction or dysfunction.
Obstructive azoospermia is the condition where sperm production is normal but the vas deferens or epididymis is blocked, preventing sperm from reaching the ejaculate. It produces a characteristic hormonal profile (normal FSH, normal testicular volume) that distinguishes it from non-obstructive azoospermia.
Causes include:
-
Congenital bilateral absence of the vas deferens (CBAVD): Often associated with mutations in the CFTR gene (cystic fibrosis gene). Both vas deferens are absent from birth, meaning there is no path for sperm to travel from the epididymis to the ejaculate. Sperm can be retrieved directly from the epididymis (MESA) or testes (TESE) for use in ICSI.
-
Previous vasectomy: Men who have undergone vasectomy and later wish to restore fertility can undergo vasectomy reversal (vasovasostomy or vasoepididymostomy). Success rates depend primarily on the time elapsed since vasectomy.
-
Post-infective obstruction: Epididymal obstruction following untreated or inadequately treated sexually transmitted infections, particularly Chlamydia trachomatis, or following complications of mumps orchitis. Surgical reconstruction may restore patency in selected cases.
-
Ejaculatory duct obstruction: Identified on transrectal ultrasound, it can be treated through transurethral resection of the ejaculatory ducts in appropriate cases.
For men with obstructive azoospermia who are not candidates for surgical reconstruction, sperm retrieval (MESA, PESA, TESE) combined with ICSI achieves good fertilisation and pregnancy rates.
The India-Specific Risk Factors Most Men Overlook
Several causes of male infertility are particularly prevalent in the urban Indian male population and deserve specific attention:
-
Anabolic steroids and unsupervised gym supplements: Research confirms that unsupervised use of anabolic steroids, testosterone supplements, and certain protein additives affects 10 to 15% of male infertility patients in India. Exogenous testosterone completely suppresses intratesticular testosterone production and sperm generation. The testes shrink. Sperm production stops. Many men using testosterone supplements for fitness goals are unaware they are inducing infertility. Cessation of testosterone and a supervised recovery protocol can restore sperm production in most cases, but recovery takes months and is not guaranteed.
-
Prolonged heat exposure and sedentary work: IT professionals and desk-based workers sitting for 8 to 10 hours daily are at specific risk. The scrotal temperature is approximately 2 to 4 degrees Celsius below core body temperature for a physiological reason: spermatogenesis requires a cooler environment. Prolonged laptop use on the lap, sustained sitting, and wearing tight synthetic clothing all raise scrotal temperature chronically. Research confirms that IT professionals form a disproportionate share of Indian male infertility presentations.
-
Chronic stress and sleep disruption: Chronic psychological stress and sleep deprivation suppress gonadotropin secretion and testosterone production, and increase oxidative stress in the reproductive system.
-
Environmental and occupational exposures: Pesticide exposure in agricultural workers, heavy metal exposure in industrial occupations, and air pollution in urban environments are documented contributors to sperm quality decline in Indian men.
Sperm DNA Fragmentation: The Cause a Semen Analysis Cannot See
A normal semen analysis is reassuring. However, it does not measure sperm DNA integrity. This is clinically significant because sperm DNA fragmentation (SDF) refers to breaks in the DNA strands carried within sperm cells, and elevated fragmentation is associated with failed fertilisation, poor embryo quality, and recurrent pregnancy loss, even when all standard semen parameters are within normal range.
A 2025 meta-analysis confirmed that varicocele is associated with a 13.62% increase in sperm DNA fragmentation, and impaired glucose tolerance (a pre-diabetic state) contributes a comparable 13.75% increase. Both conditions are highly prevalent in urban Indian men and frequently coexist. A man with varicocele and borderline blood sugar may have a semen analysis that appears technically normal while carrying sufficient DNA fragmentation to account for repeated IVF failure or unexplained recurrent miscarriage.
The WHO 2021 laboratory guidelines recognise sperm DNA fragmentation testing as a standard extended functional test. Any man with unexplained infertility, recurrent IVF failure, or recurrent pregnancy loss where no female cause has been identified should have SDF testing. It must be specifically requested.
Also Read: https://www.who.int/publications/i/item/9789240030787
Treatment of elevated SDF includes varicocelectomy (when varicocele is present), intensive antioxidant supplementation, management of metabolic risk factors, and in cases where medical management cannot adequately reduce fragmentation, surgical sperm retrieval from the testis for ICSI (where sperm are retrieved closer to their point of production and carry lower DNA damage than ejaculated sperm).
Lifestyle Modifications That Genuinely Improve Sperm Quality
Sperm are regenerated approximately every 74 days. This means that improvements in lifestyle today produce measurably better sperm within three months, a directly actionable window for couples trying to conceive.
Evidence-supported lifestyle modifications for male fertility include:
-
Maintaining a healthy weight: Obesity is associated with elevated oestrogen, reduced testosterone, and worsened sperm parameters. Weight reduction in obese men measurably improves sperm count, motility, and DNA integrity.
-
Stopping anabolic steroids and testosterone supplements: As discussed above, cessation is the single most important step for men using these substances. Reducing alcohol intake: Chronic heavy alcohol use is associated with impaired Leydig cell function, reduced testosterone production, and direct toxic effects on sperm.
-
Quitting smoking: Tobacco smoke contains oxidative compounds that damage sperm DNA and reduce sperm count and motility.
-
Antioxidant supplementation: Clinical evidence supports the use of combined antioxidant supplementation (Vitamin C 1000mg, Vitamin E 400IU, CoQ10 200-400mg, zinc 25mg, folate 400mcg) to reduce oxidative sperm damage, particularly in idiopathic infertility and elevated DNA fragmentation.
-
Reducing heat exposure: Avoiding prolonged laptop use on the lap, switching to looser clothing, and taking regular breaks from sitting all reduce scrotal temperature and support sperm production.
Assisted Reproduction: When Other Treatments Are Not Enough
For men where the underlying cause cannot be corrected or where ART achieves better outcomes than other approaches, assisted reproduction offers highly effective solutions:
-
IUI (Intrauterine Insemination): Suitable for mild male factor infertility with a total motile sperm count above the threshold for adequate IUI outcomes. Prepared sperm is placed directly into the uterine cavity around the time of ovulation.
-
IVF (In Vitro Fertilisation): Standard IVF allows sperm to fertilise eggs naturally in the laboratory environment. Used for moderate male factor infertility.
-
ICSI (Intracytoplasmic Sperm Injection): A single sperm is injected directly into each egg. ICSI is the treatment of choice for severe male factor infertility, including severe oligozoospermia, poor morphology, elevated DNA fragmentation, and all forms of azoospermia where sperm are retrieved surgically. As confirmed by the AUA/ASRM guideline, intrauterine insemination success rates may be reduced with low total motile sperm counts, and IVF/ICSI may be considered in such cases.
-
Surgical sperm retrieval (TESE, MESA, PESA): Sperm retrieved directly from the testes or epididymis are used with ICSI for men with obstructive azoospermia and selected cases of non-obstructive azoospermia where focal sperm production remains.
Male Fertility Care at Dr. Humayun Speciality Hospital, T. Nagar, Chennai
At Dr. Humayun Speciality Hospital, male infertility is evaluated and treated as a priority clinical concern equal to female fertility investigation, within the same integrated reproductive medicine framework.
Services for men include a detailed andrological consultation, two-sample semen analysis with strict Kruger morphology assessment, hormonal evaluation (FSH, LH, testosterone, prolactin), scrotal and transrectal Doppler ultrasound for varicocele assessment, sperm DNA fragmentation testing, Y-chromosome microdeletion and karyotyping referral where indicated, and coordinated treatment planning across lifestyle optimisation, medical management, surgical referral for varicocelectomy or sperm retrieval, and ART (IUI, IVF, ICSI) where required.
The team's approach is built on a single principle: the treatment must be matched to the cause. A semen analysis report is the beginning of the investigation, not the end of it.
The Evaluation You Have Been Putting Off Is the Place to Start
Male infertility is not a reflection of identity or capability. It is a medical condition with identifiable causes and effective treatments. The only thing that stands between most men and a clear answer is a conversation and a semen analysis.
Had a semen analysis that came back abnormal, or been trying to conceive without success?
Chat with our care assistant for quick guidance and support and book a male fertility evaluation at Dr. Humayun Speciality Hospital, T. Nagar, Chennai.
